glp-1 weight loss clinical trials Lilly orforglipron oral phase 3 trial GLP-1 Clinical Trials: Opportunity for

Why combination research differs from single-compound studies Combination studies require a different research design than single-compound studies, since researchers need to account for potential interactions between two active mechanisms rather than measuring a single variable in isolation

stomach pain increased salivation quick heavy breathing tachycardia 1) hypertension headache pale skin muscle fasciculations & weakness seizures Late inhibitory phase (including Muscle paralysis & Ganglionic blockade) (30 mins to an hour): bradycardia diarrhea dyspnea shallow breathing hypotension lethargy / coma severe muscle weakness & paralysis respiratory failure (paralysis of diaphragm) Pharmacokinetics: Nicotine is well absorbed through the skin Major drug Interactions: May alter the pharmacokinetics of certain concomitant medications, such as tricyclic antidepressants and theophylline

Malde et al

For more information: www.augmenix.com

Why is gut barrier integrity important

Formulated with clinically tested Carnipure, Garcinia Cambogia, and Potassium to help reduce cravings, water weight, and support an active lifestyle